Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
暂无分享,去创建一个
[1] C. Garbe,et al. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. , 2002, The Journal of investigative dermatology.
[2] Tomas Ganz,et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.
[3] Marie-Paule Strub,et al. Structure of the cathelicidin motif of protegrin-3 precursor: structural insights into the activation mechanism of an antimicrobial protein. , 2002, Structure.
[4] R. Gallo,et al. Cathelicidins, essential gene-encoded mammalian antibiotics , 2002, Journal of Molecular Medicine.
[5] R. Bals,et al. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. , 2002, American journal of respiratory and critical care medicine.
[6] L. Björck,et al. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G , 2002, The EMBO journal.
[7] Giorgio Gabella,et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.
[8] Balaji Ramanathan,et al. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. , 2002, Microbes and infection.
[9] P. Elsbach,et al. Host Defense Functions of Proteolytically Processed and Parent (Unprocessed) Cathelicidins of Rabbit Granulocytes , 2002, Infection and Immunity.
[10] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[11] T. Ganz,et al. Overexpression and structural study of the cathelicidin motif of the protegrin-3 precursor. , 2002, Biochemistry.
[12] Takaaki Ohtake,et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.
[13] V. Nizet,et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.
[14] J. Calafat,et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.
[15] S. Hamada,et al. Specific Antibodies to Porphyromonas gingivalisLys-Gingipain by DNA Vaccination Inhibit Bacterial Binding to Hemoglobin and Protect Mice from Infection , 2001, Infection and Immunity.
[16] B. Christensson,et al. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator , 2001, Nature Medicine.
[17] T. Ganz,et al. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. , 2001, Blood.
[18] A. Kulkarni,et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing , 2000, Nature Medicine.
[19] K. Seydel,et al. Entamoeba histolytica cysteine proteinases with interleukin‐1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis , 2000, Molecular microbiology.
[20] H. G. Boman. Innate immunity and the normal microflora , 2000, Immunological reviews.
[21] R. Gennaro,et al. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. , 2000, Biopolymers.
[22] James M. Wilson,et al. Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide , 1999, Infection and Immunity.
[23] F C Kafatos,et al. Phylogenetic perspectives in innate immunity. , 1999, Science.
[24] R. Bals,et al. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. , 1999, The Journal of clinical investigation.
[25] J. Musser,et al. Extracellular Cysteine Protease Produced by Streptococcus pyogenes Participates in the Pathogenesis of Invasive Skin Infection and Dissemination in Mice , 1999, Infection and Immunity.
[26] E. Veerman,et al. Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. , 1998, Biological chemistry.
[27] R. Gennaro,et al. Biological characterization of a novel mammalian antimicrobial peptide. , 1998, Biochimica et biophysica acta.
[28] Alan J. Waring,et al. Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.
[29] R. Bals,et al. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Zanetti,et al. Structural organization of the bovine cathelicidin gene family and identification of a novel member 1 , 1997, FEBS letters.
[31] D. Bainton,et al. The Human Antibacterial Cathelicidin, hCAP-18, Is Synthesized in Myelocytes and Metamyelocytes and Localized to Specific Granules in Neutrophils , 1997 .
[32] J. Schröder,et al. A peptide antibiotic from human skin , 1997, Nature.
[33] H. Wigzell,et al. The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.
[34] C. Kozak,et al. Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.
[35] R. Lehrer,et al. Designer Assays for Antimicrobial Peptides , 1997 .
[36] R. Lehrer,et al. Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. , 1997, Methods in molecular biology.
[37] T. Ganz,et al. Antimicrobial peptides of leukocytes , 1997, Current opinion in hematology.
[38] D. Bainton,et al. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. , 1997, Blood.
[39] R. Hancock,et al. Mode of Action of the Antimicrobial Peptide Indolicidin* , 1996, The Journal of Biological Chemistry.
[40] B. Lenarčič,et al. Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides. , 1996, European journal of biochemistry.
[41] J. Odeberg,et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. , 1996, European journal of biochemistry.
[42] E. Valore,et al. Intramolecular inhibition of human defensin HNP-1 by its propiece. , 1996, The Journal of clinical investigation.
[43] K. Agarwala,et al. A cysteine protease inhibitor stored in the large granules of horseshoe crab hemocytes: purification, characterization, cDNA cloning and tissue localization. , 1996, Journal of biochemistry.
[44] J. Odeberg,et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[45] T. Tezuka,et al. Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin α in skin cornified envelope , 1994, FEBS letters.
[46] M. Klagsbrun,et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] D. Verbanac,et al. Chemotactic and protease‐inhibiting activities of antibiotic peptide precursors , 1993, FEBS letters.
[48] R. Gennaro,et al. Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides. , 1991, Journal of immunology.
[49] H. Horstmann,et al. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules , 1990, The Journal of cell biology.
[50] V. Turk,et al. Primary structure of a new cysteine proteinase inhibitor from pig leucocytes , 1989, FEBS letters.
[51] H V Westerhoff,et al. Magainins and the disruption of membrane-linked free-energy transduction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[52] I. Olafsson,et al. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor , 1989, Nature.
[53] A. Barrett,et al. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. , 1987, The Journal of biological chemistry.
[54] A. Barrett,et al. Elastinolytic activity of human cathepsin L. , 1986, The Biochemical journal.
[55] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .